TipRanks
Radiopharm Theranostics Limited (AU:RAD)
ASX:RAD
Australian Market
RAD
Radiopharm Theranostics Limited
RESEARCH TOOLSreports
Want to see AU:RAD full AI Analyst Report?

Radiopharm Theranostics Limited (RAD) Income Statement

25 Followers

Radiopharm Theranostics Limited Income Statement

Last quarter (Q4 2026), Radiopharm Theranostics Limited's total revenue was AU$1.38M, an increase of 361.97% from the same quarter last year. In Q4, Radiopharm Theranostics Limited's net income was AU$-28.18M. See Radiopharm Theranostics Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 26Jun 25Jun 24Jun 23Jun 22
Total Revenue
AU$ 2.77MAU$ 13.40MAU$ 299.23KAU$ 292.36KAU$ 8.83K
Gross Profit
AU$ -2.15MAU$ 9.81MAU$ -21.31MAU$ -3.00MAU$ -2.97M
Operating Expenses
AU$ 66.18MAU$ 47.98MAU$ 27.56MAU$ 37.29MAU$ 16.94M
Depreciation and Amortization
AU$ 7.33KAU$ 2.60MAU$ 3.13MAU$ 3.30MAU$ 2.98M
EBITDA
AU$ -68.32MAU$ -31.65MAU$ -45.38MAU$ -37.11MAU$ -18.04M
Operating Income
AU$ -68.33MAU$ -38.17MAU$ -47.21MAU$ -40.29MAU$ -19.92M
Other Income/Expenses
AU$ 11.43MAU$ -65.30KAU$ -642.89KAU$ -198.31KAU$ -10.38M
Pretax Income
AU$ -56.90MAU$ -38.24MAU$ -47.85MAU$ -40.49MAU$ -30.29M
Net Income
AU$ -55.15MAU$ -36.70MAU$ -47.95MAU$ -34.61MAU$ -30.34M
Per Share Metrics
Basic EPS
AU$ -0.02AU$ -0.02AU$ -0.12AU$ -0.11AU$ -0.11
Diluted EPS
AU$ -0.02AU$ -0.02AU$ -0.12AU$ -0.11AU$ -0.11
Weighted Average Shares Outstanding
 3.54B 2.09B 386.46M 323.82M 279.77M
Weighted Average Shares Outstanding (Diluted)
 3.54B 2.09B 386.46M 323.82M 279.77M
Currency in AUD

Radiopharm Theranostics Limited Earnings and Revenue History